Catalyst Wire Dossier Catalyst Wire Dossier

Norethindrone/Ethinyl Estradiol chewable tablets 0.4 mg/35 mcg

Norethindrone and Ethinyl Estradiol · Teva Pharmaceuticals USA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Norethindrone/Ethinyl Estradiol chewable tablets 0.4 mg/35 mcg, covering 2011-05-30 to 2011-05-30. Get the full timeline:

Most recent: Clinical Trial Update: Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions [Phase 1]

See pricing